News

Economou Receives Sigma Xi Faculty Research Award

Demetre Economou, John & Rebecca Moores Professor of Chemical Engineering
Demetre Economou, John & Rebecca Moores Professor of Chemical Engineering

UH Chemical Engineering Professor Demetre Economou has been selected as the 2002 recipient of the Sigma Xi Faculty Research Award "for distinguished contributions to scientific knowledge and its applications." The award, given by the Houston chapter of the organization, includes a $2,000 prize.

Economou will also give the Sigma Xi lecture to the University community this fall.

Economou's research focuses on plasma science and technology as applied to etching and deposition of thin solid films for microelectronic device fabrication, environmental remediation, and surface modification of materials, (e.g., biomaterials). He received a bachelor's degree in chemical engineering from the National Technical University of Athens, Greece, and a Ph.D. from the University of Illinois at Urbana-Champaign in 1986. He is a John and Rebecca Moores Professor and the Associate Chairman of the Chemical Engineering department.

Sigma Xi, The Scientific Research Society, which was founded in 1886, is a nonprofit organization of nearly 75,000 scientists and engineers who were elected to the Society because of their research achievements or potential. Sigma Xi has more than 500 chapters at universities and colleges, government laboratories and industry research centers.

In addition to publishing the popular magazine American Scientist, Sigma Xi awards grants annually to promising young researchers, holds forums on critical issues at the intersection of science and society, and sponsors a variety of programs supporting honor in science and engineering, science education, science policy and the public understanding of science.

Faculty: 

Department/Academic Programs: 

Related News Stories

University of Houston Partners with AuraVax Therapeutics on COVID-19 Vaccine

Navin Varadarajan, M.D. Anderson Professor of Chemical and Biomolecular Engineering, has created a nasal vaccine for COVID-19 and a company to market it in partnership with the University of Houston.

The University of Houston has entered into an exclusive license option agreement with AuraVax Therapeutics Inc., a Houston, TX based biotech company developing novel vaccines to help patients defeat debilitating respiratory diseases such as COVID-19. Under terms of the agreement, AuraVax has the option to exclusively license a new intranasal COVID-19 vaccine technology developed by Dr. Navin Varadarajan, M.D. Anderson Professor of Chemical and Biomolecular Engineering.

Faster swimming bacteria could help with spills

Narendra Dewangan, a graduate student of Dr. Jacinta Conrad, has completed work with the Conrad Research Group on how faster swimming bacteria could be used to help with removal of pollutants.

A new paper and research from the Conrad Research Group of the Department of Chemical and Biomolecular Engineering at the University of Houston’s Cullen College of Engineering looks at how bacteria could be used to help with removal of pollutants, like in oil spills and wastewater treatment.

Rapid tests for COVID-19 now, other diseases later the goal for Kourentzi

Dr. Katerina Kourentzi, Research Associate Professor of Chemical and Biomolecular Engineering, is developing a saliva-based lateral flow assay rapid test for COVID-19 detection. The test strips for the assay are designed using the Biodot XYZ3060 Dispensing Platform.

The development of point-of-care tests – and as of late, for COVID-19 – has been the primary focus of Dr. Katerina Kourentzi, Research Associate Professor of Chemical and Biomolecular Engineering in the William A. Brookshire Department of Chemical and Biomolecular Engineering at the University of Houston's Cullen College of Engineering.